Inhibition of STAT3 induced down-regulation of collagen synthesis and regression of hypertrophy, suggesting that STAT3 is a major potential therapeutic target for cardiac hypertrophy (130). This evidence concerns the gene STAT3 and cardiac hypertrophy.